This company has been marked as potentially delisted and may not be actively trading. Pharmaceutical Resources (PRX) News Today Add Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period ASX Small Caps Lunch Wrap: Local benchmarks take cue from Wall StreetOctober 13, 2024 | msn.comNRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comCRPGF China Resources Pharmaceutical Group LimitedAugust 14, 2024 | seekingalpha.comAcurx Pharmaceuticals, Inc. (ACXP) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comRecursion Pharmaceuticals, Inc. (RXRX) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comLexicon Pharmaceuticals Needs To See Real Revenue Acceleration And Clinical/Regulatory SuccessAugust 3, 2024 | seekingalpha.comVertex Pharmaceuticals, Inc. (VRTX) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | seekingalpha.comPIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to ShareholdersJuly 24, 2024 | tmcnet.com‘Life after cancer’: Nigerian survivors challenge taboos, push for better health careMay 13, 2024 | msn.comNvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To KnowMay 9, 2024 | msn.comClosing Bell: ASX rallies hard as RBA holds rates; Bonza drama continues with court rulingMay 7, 2024 | msn.comLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call TranscriptMay 6, 2024 | msn.comPharmacies getting back on track after Change Healthcare hackMarch 12, 2024 | msn.comARS Pharmaceuticals (SPRY) Price Target Increased by 56.25% to 12.75February 25, 2024 | msn.comPharmaScroll Unveils Groundbreaking Expansion of Key Opinion Leader Database: Empowering Pharmaceutical Industry with Cutting-Edge Market InsightsJanuary 29, 2024 | tmcnet.comIberdrola terminates $8.3bn PNM Resources mergerJanuary 4, 2024 | msn.comRocket Pharmaceuticals to Present at 42 nd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2024 | businesswire.comCAN, CALT and PRZO are among pre market gainersDecember 21, 2023 | msn.comRecursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.November 26, 2023 | msn.comPre-Sterilized/Ready to Use Pharmaceutical Packaging Market, 2035 - ResearchAndMarkets.comOctober 24, 2023 | businesswire.com2 pharmaceutical companies to pay $120M in 3rd Kentucky settlementOctober 24, 2023 | msn.comSpherix Introduces Patient Chart Dynamix™, an Enhanced Independent Pharmaceutical Market Research Chart AuditSeptember 26, 2023 | benzinga.comWhy Crinetics Pharmaceuticals Stock Soared This WeekSeptember 15, 2023 | msn.comPharmaceutical Temperature-Controlled Packaging Market, 2028 - Pharma TCP Market Digitization to Cut Costs and Streamline Processes - ResearchAndMarkets.comSeptember 4, 2023 | businesswire.comGlobal Drug and Pharmaceutical Machinery Market 2023-2030 by Size|Precisionreports.coMay 17, 2023 | marketwatch.comPharmaceutical Cartridges Market by 2030May 14, 2023 | marketwatch.comPharmaceutical Labeling Market Research | 2023-2030May 11, 2023 | marketwatch.comPharmaceutical Inks Market Research | 2023-2030May 11, 2023 | marketwatch.comPharmaceutical Grade Dextran Market Future Scope and Growth Status 2031May 11, 2023 | marketwatch.comLatest Updates on Pharmaceutical outsourcing Market from Industry Experts | 2023 to 2030May 11, 2023 | marketwatch.comChina Resources Pharmaceutical Group (3320) Price Target Increased by 10.39% to 8.07May 11, 2023 | msn.comDrug and Pharmaceutical Machinery Market Size, 2030May 8, 2023 | marketwatch.comPharmaceutical Contract Packaging Market Research Findings to 2030May 5, 2023 | marketwatch.com2023 Pharmaceutical Equipment Market To Deliver Greater Revenues during the Forecast Period until 2030May 5, 2023 | marketwatch.comPharmaceutical Warehousing Market Demand by 2031April 29, 2023 | marketwatch.comPharmaceutical CRM Software Market Demand by 2031April 28, 2023 | marketwatch.comPharmaceutical Drugs for Therapy Market Growth by 2031April 28, 2023 | marketwatch.comPharmaceutical Packaging Market Forecast to 2030April 27, 2023 | marketwatch.comDrug and Pharmaceutical Machinery Market 2023 Prospects, Upcoming Trends and Competitive Outlook till 2029April 27, 2023 | marketwatch.comGlobal Pharmaceutical Cartridges Market Insights and Forecast to 2028April 26, 2023 | marketwatch.comLatest Trends and Strategies for Pharmaceutical Retail Market During 2023-2031April 22, 2023 | marketwatch.comPharmaceutical & Medical Flexible Packaging Market | Extensive Growth by 2030April 20, 2023 | marketwatch.comPharmaceutical Cartridges Market Market Trends By 2030April 18, 2023 | marketwatch.comMR Reporting Software For Pharmaceutical Market Key Vendors and Forecast till 2031April 17, 2023 | marketwatch.comChina Resources Boya Bio-pharmaceutical Group Co Ltd Class A 300294 Stock QuoteApril 16, 2023 | morningstar.comPharmaceutical Drug Delivery Market Forecast to 2031April 14, 2023 | marketwatch.comPharmaceutical Lab Equipment Market 2023 Size and Forecast to 2031April 8, 2023 | marketwatch.comPharmaceutical Contract Manufacturing & Contract Market Size | Statistics By 2031April 7, 2023 | marketwatch.comPharmaceutical Industry Software Market Revenue By 2031April 6, 2023 | marketwatch.comPharmaceutical Contract Research and Manufacturing (CRAM) Market 2023 Size and Forecast to 2031April 6, 2023 | marketwatch.com Get Pharmaceutical Resources News Delivered to You Automatically Sign up to receive the latest news and ratings for PRX and its competitors with MarketBeat's FREE daily newsletter. Email Address PRX Media Mentions By Week PRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRX News Sentiment▼0.000.37▲Average News Sentiment PRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRX Articles This Week▼00▲PRX Articles Average Week Get Pharmaceutical Resources News Delivered to You Automatically Sign up to receive the latest news and ratings for PRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PRX) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmaceutical Resources Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharmaceutical Resources With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.